Renalytix (LSE:RENX) Days Sales Outstanding : 154.88 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Renalytix Days Sales Outstanding?

Renalytix's average Accounts Receivable for the three months ended in Dec. 2023 was £0.95 Mil. Renalytix's Revenue for the three months ended in Dec. 2023 was £0.56 Mil. Hence, Renalytix's Days Sales Outstanding for the three months ended in Dec. 2023 was 154.88.

The historical rank and industry rank for Renalytix's Days Sales Outstanding or its related term are showing as below:

LSE:RENX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 75.2 Med: 87.47 Max: 143.33
Current: 143.33

During the past 6 years, Renalytix's highest Days Sales Outstanding was 143.33. The lowest was 75.20. And the median was 87.47.

LSE:RENX's Days Sales Outstanding is ranked worse than
91.86% of 639 companies
in the Healthcare Providers & Services industry
Industry Median: 46.55 vs LSE:RENX: 143.33

Renalytix's Days Sales Outstanding increased from Dec. 2022 (81.70) to Dec. 2023 (154.88).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Renalytix Days Sales Outstanding Historical Data

The historical data trend for Renalytix's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renalytix Days Sales Outstanding Chart

Renalytix Annual Data

Trend

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

75.20

87.47

91.22

Renalytix Quarterly Data
	Dec18	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															81.70	98.51	136.99	176.35	154.88

Competitive Comparison of Renalytix's Days Sales Outstanding

For the Health Information Services subindustry, Renalytix's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Renalytix's Days Sales Outstanding Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Renalytix's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Renalytix's Days Sales Outstanding falls into.

Renalytix Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Renalytix's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.732	+	0.615)	/	2 )	/	2.695	*	365
=	0.6735					/	2.695	*	365
=	91.22

Renalytix's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.819	+	1.082)	/	2 )	/	0.56	*	365 / 4
=	0.9505					/	0.56	*	365 / 4
=	154.88

Renalytix (LSE:RENX) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Renalytix Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Renalytix's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Renalytix (LSE:RENX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Renalytix PLC (LSE:RENX) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RNLX:USA RTNXF:USA 2O9:Germany

Address

5-7 Cranwood Street, Finsgate, London, GBR, EC1V 9EE

Website

https://www.renalytix.com

Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Renalytix (LSE:RENX) Headlines

From GuruFocus

Investing in Information

By Vanina Egea Vanina Egea • 03-06-2014

Paul Singer Buys Reed Elesvier

By matsandalex matsandalex • 12-14-2012

Causeway International's Top Five Holdings

By Monica Wolfe Monica Wolfe • 08-29-2013

Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.

By PRNewswire PRNewswire • 03-27-2018